spacer
home > epc > Autumn 2018
PUBLICATIONS

European Pharmaceutical Contractor

epc
Autumn 2018

   
Text
PDF
bullet
Legal & Regulatory
Risk-Averse Cultures in New Product Development

Accelerating Development

Brion Regan at ERT discusses the surge in technological developments across the pharmaceutical industry, highlighting that their adoption across the field is low.
 
view
download pdf
Applying Quality Best Practice Principles

Quality Compliance

Patricia Santos-Serrao at MasterControl breaks the traditional view that clinical and manufacturing in life sciences operate in separate spheres by exploring the similarities they share.
 
view
download pdf
Clinical Partnerships in the NHS

Clinical Service

Bernard Ross at Sky Medical Technology puts forward the notion that the pharmaceutical and biotechnology industries need to prioritise clinical partnerships through clinician-first approaches.
 
view
download pdf
Application of Good Clinical Practice Principles

Right First and Every Time

One historic challenge in clinical research has been maintaining the balance between safety and effectiveness. Dr Suzanne Pavon at TFS explores different management approaches to combat this.
 
view
download pdf
   
spacer



Published quarterly in
February, May,
August, and November

News and Press Releases

MedPharm’s CSO and University of Reading Professor co-author new book on dermal formulation development

MedPharm’s Chief Scientific Officer and Co-Founder, Professor Marc Brown and University of Reading’s Professor Adrian Williams have co-authored the new book: ‘The Art and Science of Dermal Formulation Development”. It is the latest addition to ‘Drugs and the Pharmaceutical Sciences’, a series of textbooks and monographs published by CRC Press.
More info >>

White Papers

pAVEway™ expression system for the efficient expression of therapeutic proteins

Fujifilm Diosynth Biotechnologies

One of the major bottlenecks in the production of biopharmaceuticals is the efficient expression of therapeutic proteins in microbial or mammalian cells. The Escherichia coli pAVEway™ expression system described here has been developed to ensure high product titres and efficient scale up to GMP manufacture, whilst minimising many common issues seen in other expression systems, such as ‘leaky’ expression (expression of recombinant protein in the absence of inducer).
More info >>

Industry Events

CPhI & P-MEC China

18-20 June 2019, SNIEC, Shanghai, China

CPhI & P-MEC China 2019 is your gateway to successfully grow your business at the 2nd largest pharma market in the world. Whether you are looking for sourcing new business or getting the latest market insight, this is your one-stop shop pharmaceutical platform in Asia.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement